Monday, 31 August 2026European Markets

ST DUPONT Stock 10.06% Up On Wednesday

Loading stream...

(vianews) - the market ended the session with st dupont (dpt.pa) jumping 10.06% to €0.07 on wednesday, after five successive sessions in a row of losses. cac 40 jumped 0.91% to €7,455.64, following the last session's downward trend on what was a somewhat bullish trend trading session today.

st dupont's last close was €0.06, 55.13% below its 52-week high of €0.14.

about st dupont

s.t. dupont s.a. designs, manufactures, and sells luxury products in france and internationally. the company offers lighters, pens, and leather goods; accessories, such as belts, tie bars, money clips, and key rings; cigar accessories and ashtrays; writing accessories; and fragrances. it sells its products through stores and online. s.t. dupont s.a. was incorporated in 1934 and is based in faverges, france. s.t. dupont s.a. is a subsidiary of d and d international b.v.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -75.84%.

moving average

st dupont's value is way under its 50-day moving average of €0.09 and way below its 200-day moving average of €0.11.

revenue growth

year-on-year quarterly revenue growth grew by 24.9%, now sitting on 50.23m for the twelve trailing months.

more news about st dupont (dpt.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com